A comprehensive view of Celltrion Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
South Korea-based Celltrion announces licensing contract with UN Medicine Patent Pool to manufacture generic version of Pfizer's oral COVID-19 treatment
Published:
March 22, 2022
by Asian News International
|
FDA alerts against using Celltrion's DiaTrust COVID-19 Ag Rapid Tests due to risk of false results; test has not been authorized, cleared or approved by the FDA
Published:
March 02, 2022
by ForeignAffairs.co.nz
|
Ask us about our Tissue & Hygiene market view
Trending Chart
Interactive chart with headline count